Raphael Pharmaceutical Inc.
Recent Filings
All 173 filings →| Form | Description | Date |
|---|---|---|
| 8-K | CURRENT REPORT | Mar 24, 2026 |
| 10-Q | QUARTERLY REPORT | Nov 13, 2025 |
| 3 | OWNERSHIP DOCUMENT | Sep 8, 2025 |
| 10-Q | QUARTERLY REPORT | Aug 13, 2025 |
| 8-K | CURRENT REPORT | Aug 11, 2025 |
| 8-K | CURRENT REPORT | Aug 11, 2025 |
| 10-Q | QUARTERLY REPORT | May 15, 2025 |
| 10-K | ANNUAL REPORT | Mar 31, 2025 |
| 4 | — | Mar 12, 2025 |
| 4 | — | Mar 11, 2025 |
Insider Transactions
View all →| Insider | Title | Type | Shares | Owns After | Date |
|---|---|---|---|---|---|
| Dhadha Ajay Kumar | — | Award / Grant | 350,000 | 351,667 | Mar 5, 2025 |
| Pilo Shlomo | Chief Executive Officer | Award / Grant | 200,000 @ $0.50 | 3,983,701 | Mar 2, 2025 |
| Eliya Yehuda | — | Award / Grant | 150,000 @ $0.40 | 352,000 | Nov 25, 2023 |
| Press Joseph | — | Award / Grant | 280,000 | 280,000 | Jul 26, 2022 |
| Ofir Guy | Chief Financial Officer | Award / Grant | 1,000,000 | 1,266,455 | Jul 26, 2022 |
| Ofir Guy | President | Purchase | 286,000 @ $0.06 | 3,875,800 | Oct 28, 2009 |
| Ofir Guy | President | Purchase | 404,153 @ $0.10 | 20,724,153 | Sep 22, 2009 |
| Ofir Guy | President | Purchase | 100,000 @ $0.07 | 20,320,000 | Dec 2, 2008 |
| Ofir Guy | President | Purchase | 15,000 @ $0.08 | 20,120,000 | Nov 4, 2008 |
| Ofir Guy | President | Purchase | 5,000 @ $0.14 | 3,510,000 | Oct 2, 2008 |